Organization

Jeffrey Rade

1 clinical trial

Clinical trial

The Thromboxane Receptor Antagonist to Blunt the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Cell Function (TRAP) Trial

Status: Active (not recruiting), Estimated PCD: 2022-11-07